Your browser doesn't support javascript.
loading
Alternative genomic diagnoses for individuals with a clinical diagnosis of Dubowitz syndrome.
Dyment, David A; O'Donnell-Luria, Anne; Agrawal, Pankaj B; Coban Akdemir, Zeynep; Aleck, Kyrieckos A; Antaki, Danny; Al Sharhan, Hind; Au, Ping-Yee B; Aydin, Hatip; Beggs, Alan H; Bilguvar, Kaya; Boerwinkle, Eric; Brand, Harrison; Brownstein, Catherine A; Buyske, Steve; Chodirker, Bernard; Choi, Jungmin; Chudley, Albert E; Clericuzio, Carol L; Cox, Gerald F; Curry, Cynthia; de Boer, Elke; de Vries, Bert B A; Dunn, Kathryn; Dutmer, Cullen M; England, Eleina M; Fahrner, Jill A; Geckinli, Bilgen B; Genetti, Casie A; Gezdirici, Alper; Gibson, William T; Gleeson, Joseph G; Greenberg, Cheryl R; Hall, April; Hamosh, Ada; Hartley, Taila; Jhangiani, Shalini N; Karaca, Ender; Kernohan, Kristin; Lauzon, Julie L; Lewis, M E Suzanne; Lowry, R Brian; López-Giráldez, Francesc; Matise, Tara C; McEvoy-Venneri, Jennifer; McInnes, Brenda; Mhanni, Aziz; Garcia Minaur, Sixto; Moilanen, Jukka; Nguyen, An.
Afiliação
  • Dyment DA; Department of Genetics, Children's Hospital of Eastern Ontario, Ottawa, Ontario, Canada.
  • O'Donnell-Luria A; Children's Hospital of Eastern Ontario Research Institute, Ottawa, Ontario, Canada.
  • Agrawal PB; Broad Institute of MIT and Harvard, Broad Center for Mendelian Genomics, Cambridge, Massachusetts, USA.
  • Coban Akdemir Z; Division of Genetics and Genomics, Boston Children's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
  • Aleck KA; The Manton Center for Orphan Disease Research, Boston Children's Hospital, Boston, Massachusetts, USA.
  • Antaki D; Division of Genetics and Genomics, Boston Children's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
  • Al Sharhan H; The Manton Center for Orphan Disease Research, Boston Children's Hospital, Boston, Massachusetts, USA.
  • Au PB; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, USA.
  • Aydin H; Department of Genetics and Metabolism, Phoenix Children's Medical Group, Phoenix, Arizona, USA.
  • Beggs AH; Laboratory for Pediatric Brain Disease, Howard Hughes Medical Institute, University of California, San Diego, California, USA.
  • Bilguvar K; Rady Children's Institute for Genomic Medicine, Rady Children's Hospital, San Diego, California, USA.
  • Boerwinkle E; McKusick-Nathans Department of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Brand H; Department of Pediatrics, Faculty of Medicine, Kuwait University, Kuwait City, Kuwait.
  • Brownstein CA; Department of Medical Genetics and Alberta Children's Hospital Research Institute, University of Calgary, Calgary, Alberta, Canada.
  • Buyske S; Centre of Genetics Diagnosis, Zeynep Kamil Maternity and Children's Training and Research Hospital, Istanbul, Turkey.
  • Chodirker B; Division of Genetics and Genomics, Boston Children's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
  • Choi J; The Manton Center for Orphan Disease Research, Boston Children's Hospital, Boston, Massachusetts, USA.
  • Chudley AE; Department of Genetics, Yale School of Medicine, New Haven, Connecticut, USA.
  • Clericuzio CL; Yale Center for Genome Analysis, Yale School of Medicine, New Haven, Connecticut, USA.
  • Cox GF; Human Genome Sequencing Center, Baylor College of Medicine, Waco, Texas, USA.
  • Curry C; Broad Institute of MIT and Harvard, Broad Center for Mendelian Genomics, Cambridge, Massachusetts, USA.
  • de Boer E; Center for Genomic Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • de Vries BBA; Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Dunn K; Division of Genetics and Genomics, Boston Children's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
  • Dutmer CM; The Manton Center for Orphan Disease Research, Boston Children's Hospital, Boston, Massachusetts, USA.
  • England EM; Department of Statistics and Biostatistics, Rutgers University, Piscataway, New Jersey, USA.
  • Fahrner JA; Department of Biochemistry and Medical Genetics, University of Manitoba, Winnipeg, Manitoba, Canada.
  • Geckinli BB; Department of Genetics, Yale School of Medicine, New Haven, Connecticut, USA.
  • Genetti CA; Department of Biomedical Sciences, Korea University College of Medicine, Seoul, South Korea.
  • Gezdirici A; Department of Biochemistry and Medical Genetics, University of Manitoba, Winnipeg, Manitoba, Canada.
  • Gibson WT; Department of Pediatrics, University of New Mexico Health Sciences Center, Albuquerque, New Mexico, USA.
  • Gleeson JG; Division of Genetics and Genomics, Boston Children's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
  • Greenberg CR; The Manton Center for Orphan Disease Research, Boston Children's Hospital, Boston, Massachusetts, USA.
  • Hall A; University of California, San Francisco, California, USA.
  • Hamosh A; Genetic Medicine, University Pediatric Specialists, Fresno, California, USA.
  • Hartley T; Department of Human Genetics, Raboud University Medical Centre, Nijmegen, Netherlands.
  • Jhangiani SN; Department of Human Genetics, Raboud University Medical Centre, Nijmegen, Netherlands.
  • Karaca E; Donders Institute for Brain, Cognition and Behaviour, Raboud University Medical Centre, Nijmegen, Netherlands.
  • Kernohan K; The Manton Center for Orphan Disease Research, Boston Children's Hospital, Boston, Massachusetts, USA.
  • Lauzon JL; Children's Hospital Colorado and University of Colorado School of Medicine, Aurora, Colorado, USA.
  • Lewis MES; Broad Institute of MIT and Harvard, Broad Center for Mendelian Genomics, Cambridge, Massachusetts, USA.
  • Lowry RB; McKusick-Nathans Department of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • López-Giráldez F; Department of Medical Genetics, School of Medicine, Marmara University, Istanbul, Turkey.
  • Matise TC; Division of Genetics and Genomics, Boston Children's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
  • McEvoy-Venneri J; The Manton Center for Orphan Disease Research, Boston Children's Hospital, Boston, Massachusetts, USA.
  • McInnes B; Department of Medical Genetics, Kanuni Sultan Suleyman Training and Research Hospital, Istanbul, Turkey.
  • Mhanni A; Department of Medical Genetics and British Columbia Children's Hospital Research Institute, University of British Columbia, Vancouver, British Columbia, Canada.
  • Garcia Minaur S; Laboratory for Pediatric Brain Disease, Howard Hughes Medical Institute, University of California, San Diego, California, USA.
  • Moilanen J; Rady Children's Institute for Genomic Medicine, Rady Children's Hospital, San Diego, California, USA.
  • Nguyen A; Department of Biochemistry and Medical Genetics, University of Manitoba, Winnipeg, Manitoba, Canada.
Am J Med Genet A ; 185(1): 119-133, 2021 01.
Article em En | MEDLINE | ID: mdl-33098347
ABSTRACT
Dubowitz syndrome (DubS) is considered a recognizable syndrome characterized by a distinctive facial appearance and deficits in growth and development. There have been over 200 individuals reported with Dubowitz or a "Dubowitz-like" condition, although no single gene has been implicated as responsible for its cause. We have performed exome (ES) or genome sequencing (GS) for 31 individuals clinically diagnosed with DubS. After genome-wide sequencing, rare variant filtering and computational and Mendelian genomic analyses, a presumptive molecular diagnosis was made in 13/27 (48%) families. The molecular diagnoses included biallelic variants in SKIV2L, SLC35C1, BRCA1, NSUN2; de novo variants in ARID1B, ARID1A, CREBBP, POGZ, TAF1, HDAC8, and copy-number variation at1p36.11(ARID1A), 8q22.2(VPS13B), Xp22, and Xq13(HDAC8). Variants of unknown significance in known disease genes, and also in genes of uncertain significance, were observed in 7/27 (26%) additional families. Only one gene, HDAC8, could explain the phenotype in more than one family (N = 2). All but two of the genomic diagnoses were for genes discovered, or for conditions recognized, since the introduction of next-generation sequencing. Overall, the DubS-like clinical phenotype is associated with extensive locus heterogeneity and the molecular diagnoses made are for emerging clinical conditions sharing characteristic features that overlap the DubS phenotype.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas Repressoras / Predisposição Genética para Doença / Eczema / Transtornos do Crescimento / Histona Desacetilases / Deficiência Intelectual / Microcefalia Tipo de estudo: Diagnostic_studies Limite: Adolescent / Child / Child, preschool / Female / Humans / Infant / Male Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas Repressoras / Predisposição Genética para Doença / Eczema / Transtornos do Crescimento / Histona Desacetilases / Deficiência Intelectual / Microcefalia Tipo de estudo: Diagnostic_studies Limite: Adolescent / Child / Child, preschool / Female / Humans / Infant / Male Idioma: En Ano de publicação: 2021 Tipo de documento: Article